This research develops a nanocomposite for controlled drug release in tumors, suggesting low-toxicity treatment options.
We developed UCNP@organosilica nanocapsules with GSH-triggered degradation and photoresponsive feature for on-demand DOX release. NIR/pH/GSH stimuli enable controlled drug release for targeted, low-toxicity chemotherapy and tumor cell ablation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: